158 related articles for article (PubMed ID: 25663946)
1. Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody.
Thammasit P; Sangboonruang S; Suwanpairoj S; Khamaikawin W; Intasai N; Kasinrerk W; Tayapiwatana C; Tragoolpua K
J Cancer; 2015; 6(3):276-86. PubMed ID: 25663946
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
Panich T; Tragoolpua K; Pata S; Tayapiwatana C; Intasai N
Cancer Biother Radiopharm; 2017 Feb; 32(1):1-8. PubMed ID: 28118037
[TBL] [Abstract][Full Text] [Related]
3. EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2.
Sangboonruang S; Thammasit P; Intasai N; Kasinrerk W; Tayapiwatana C; Tragoolpua K
Cancer Gene Ther; 2014 Jun; 21(6):246-55. PubMed ID: 24924201
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of OKT3-induced T cell proliferation and suppression of CD147 cell surface expression in HeLa cells by scFv-M6-1B9.
Intasai N; Tragoolpua K; Pingmuang P; Khunkaewla P; Moonsom S; Kasinrerk W; Lieber A; Tayapiwatana C
Immunobiology; 2008; 214(6):410-21. PubMed ID: 19264376
[TBL] [Abstract][Full Text] [Related]
5. Generation of functional scFv intrabody to abate the expression of CD147 surface molecule of 293A cells.
Tragoolpua K; Intasai N; Kasinrerk W; Mai S; Yuan Y; Tayapiwatana C
BMC Biotechnol; 2008 Jan; 8():5. PubMed ID: 18226275
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of endoplasmic reticulum-retained anti-type IV collagenase intrabody on invasion and proliferation of cancer cell].
Shen EY; Wang WG; Li Y; Zhang SH; Zhen YS
Ai Zheng; 2004 Sep; 23(9):1005-10. PubMed ID: 15363191
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts.
Hasaneen NA; Cao J; Pulkoski-Gross A; Zucker S; Foda HD
Respir Res; 2016 Feb; 17():17. PubMed ID: 26887531
[TBL] [Abstract][Full Text] [Related]
8. EMMPRIN Down-regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1α.
Liu Y; Zhang J; Sun X; Li M
Sci Rep; 2016 Jun; 6():28329. PubMed ID: 27325313
[TBL] [Abstract][Full Text] [Related]
9. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
10. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
Yang J; Wang R; Li H; Lv Q; Meng W; Yang X
Cancer Biomark; 2016 Jul; 17(2):237-47. PubMed ID: 27434292
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer enhances host resistance against pseudomonas aeruginosa infection through MAPK signaling pathway.
Li Y; Chen L; Wang C; Chen J; Zhang X; Hu Y; Niu X; Pei D; He Z; Bi Y
Am J Transl Res; 2016; 8(12):5619-5627. PubMed ID: 28078032
[TBL] [Abstract][Full Text] [Related]
13. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Siddiquei MM; Mohammad G; Hertogh G; Mousa A; Opdenakker G
Acta Ophthalmol; 2017 Nov; 95(7):697-704. PubMed ID: 27860331
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of extracellular matrix metalloproteinase inducer promotes hypoxia-induced epithelial-mesenchymal transition in esophageal cancer.
Wu X; Qiao B; Liu Q; Zhang W
Mol Med Rep; 2015 Nov; 12(5):7419-24. PubMed ID: 26458866
[TBL] [Abstract][Full Text] [Related]
16. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Tang Y; Kesavan P; Nakada MT; Yan L
Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
[TBL] [Abstract][Full Text] [Related]
17. Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity.
Li L; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Clin Cancer Res; 2007 Apr; 13(7):2178-90. PubMed ID: 17404102
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.
Bi XC; Liu JM; Zheng XG; Xian ZY; Feng ZW; Lou YX; Zhong WD; Wu CL
Clin Invest Med; 2011 Dec; 34(6):E358. PubMed ID: 22129926
[TBL] [Abstract][Full Text] [Related]
19. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
